COMPANY
About KHAV
KHAV is a vaccine, therapeutics R&D and CRO company that contributes to human
and animal health through the development of next-generation vaccines.
-
The Leader in
One Health Vaccine
Development -
KHAV will become a global vaccine development leader that contributes
to human and animal health through vaccine development and CRO business
for zoonotic infectious diseases.
KHAV overview
-
- Company
- KHAV Co.Ltd
-
- Date of Foundation
- December 22, 2014
-
- CEO
- Dr. Chang-Seon SONG
-
- R&D
- 70%
Business Area
Development of veterinary medicines
CRO
Global vaccine businessOther
-
Konkuk University's No. 1 subsidiary
(Technology Holding Company)
-
Research connection with Konkuk
University Veterinary College
( Vaccine & CRO )
-
ISO 17025 certification
-
GLP facilities for veterinary medicinal products
-
Test facilities for animal drugs (Certified)
Clinical trial facilities for animal drugs (Certified)
-
Non-clinical trial facilities for animal drugs (Certified)
-
Research Center for National R&D project
